Jpmorgan Chase & CO Insmed Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Insmed Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,354,022 shares of INSM stock, worth $910 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,354,022
Previous 3,286,248
93.35%
Holding current value
$910 Million
Previous $227 Million
113.66%
% of portfolio
0.04%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding INSM
# of Institutions
579Shares Held
203MCall Options Held
2.84MPut Options Held
3.26M-
Darwin Global Management, Ltd. St. Helier, Y919.3MShares$2.77 Billion82.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$2.53 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$1.61 Billion0.13% of portfolio
-
Baker Bros. Advisors LP New York, NY7.71MShares$1.1 Billion7.87% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $19.4B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...